Congress of Clinical Rheumatology Annual Meeting
Gout-PsA overlap warrants new look at disease mechanisms, role of urate crystals
Psoriatic arthritis and gout often present with similar symptoms and radiological signs, an overlap that may be more significant when these diseases occur concomitantly, noted a presenter at the 2020 Congress of Clinical Rheumatology-West.
AxSpa treatment expands beyond 'workhorse' TNF inhibitors
Strong data for two interleukin-17 inhibitors have given a lift to clinicians treating the spondyloarthropathies, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.
Difficult-to-treat RA calls for reassessments of medication, diagnosis
Physicians should confront difficult-to-treat rheumatoid arthritis by rethinking the diagnosis, reassessing available medications, and — importantly — talking with the patient, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.
'Newer meds' have opened the door for 'newer concepts' in treating RA
While the broad range of available therapies to treat rheumatoid arthritis provides clinicians with options, there is still no clear-cut treatment algorithm for every patient, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.
In lupus, hydroxychloroquine blood levels matter more than dosage
Rheumatologists treating patients with systemic lupus erythematosus should focus more on hydroxychloroquine blood levels than on prescribed dosage based on weight, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.
Expert explores updated antiphospholipid syndrome guidelines via patient cases
The emergence of multiple documents outlining treatment recommendations for antiphospholipid syndrome between 2018 and 2020 has saved lives, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.
Risk for thrombotic recurrence outweighs therapy cessation in antiphospholipid syndrome
Although patients with antiphospholipid syndrome may ask to halt their anticoagulation if their symptoms are stable, there remains serious risk for recurrent thrombosis, noted a presenter at the 2020 Congress of Clinical Rheumatology-West.
Grouping SLE subsets by symptoms may help patients 'proactively manage their disease'
Grouping patients with systemic lupus erythematosus into subsets based on inflammatory and noninflammatory symptoms may help them better understand their disease and treatment, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.
Clinicians must account for myriad environmental factors when managing lupus
Understanding the interplay between environmental, genetic and other factors is critical to lupus management, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.
Congress of Clinical Rheumatology-West follows-up East meeting with all-new program
Thanks to COVID-19, the 2020 Congress of Clinical Rheumatology-West will come right on the heels of the CCR-East meeting.